Interestingly, we also found that a subgroup of intrinsically resistant melanoma cells (that have a loss of PTEN), were capable of secreting their own fibronectin in response to a number of cellular stresses including BRAF inhibitor therapy, chemotherapy, and changes in pH [4]. The gene discussed is BRAF; the disease is melanoma.